hydration benefits glp-1 receptor agonists Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Agonists: A Multidisciplinary Expert Consensus Cardiovascular benefits of glucagon-like peptide-1
Description
Clinical studies investigating the effects of DPP-4 inhibitors have yielded promising results, indicating improvements in bone density and a potential decrease in fracture incidence
References Bauer PV, Duca FA
doi: 10.1038/icb.2008.62 5 KorneteMMasonESPiccirilloCA
doi: 10.1007/s00125-008-1149-y 133 GromadaJFranklinIWollheimCB
[9] [3] Clinicians should adhere to these schedules rather than accelerating titration, even when patients are tolerating current doses well
Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
